Effects of Acamprosate on Psychomotor Performance and Driving Ability in Abstinent Alcoholics

1998 ◽  
Vol 31 (06) ◽  
pp. 232-235 ◽  
Author(s):  
M. Soyka ◽  
C. Aichmüller ◽  
U. Preuss ◽  
H.-J. Möller
Keyword(s):  
Psychomotor Performance ◽  
Driving Ability

scholarly journals Psychomotor Performance Relevant to Driving Ability in Patients with Schizophrenia Treated with Haloperidol and Aripiprazole

2012 ◽  
Vol 15 (2) ◽  
pp. 99
Author(s):  
Ji Hyun Han ◽  
Se Jin Park ◽  
Jong Il Lee ◽  
An Kee Chang ◽  
Shi Hyun Kang ◽  
...  
Keyword(s):  
Psychomotor Performance ◽  
Driving Ability

Residual Effects of Middle-of-the-Night Administration of Zaleplon and Zolpidem on Driving Ability, Memory Functions, and Psychomotor Performance

2002 ◽  
Vol 22 (6) ◽  
pp. 576-583 ◽  
Author(s):  
Joris C. Verster ◽  
Edmund R. Volkerts ◽  
Antonia H. C. M. L. Schreuder ◽  
Erik J.E. Eijken ◽  
Janet H. G. van Heuckelum ◽  
...  
Keyword(s):  
Psychomotor Performance ◽  
Residual Effects ◽  
Driving Ability ◽  
Memory Functions

Psychomotor Performance Under Neuroleptic Treatment in Schizophrenia

2001 ◽  
Vol 12 (1) ◽  
pp. 49-53 ◽  
Author(s):  
Michael Soyka ◽  
Sebastian Dittert ◽  
Martin Schäfer ◽  
Andreas Gartenmaier ◽  
Gerd Laux ◽  
...  
Keyword(s):  
Psychomotor Performance ◽  
Driving Ability ◽  
Clinical Feature ◽  
Psychomotor Function ◽  
Impaired Performance ◽  
Icd 10 ◽  
Schizophrenic Patients ◽  
Computer Based ◽  
Risperidone Group ◽  
Haloperidol Group

Abstract: Cognitive dysfunction has been recognized as an important clinical feature of schizophrenia. The possible pharmacological effect of neuroleptics on cognitive and psychomotor function including driving ability is crucial for rehabilitation of schizophrenic patients. Atypical neuroleptics such as risperidone have been shown to improve cognitive deficits in schizophrenics. We conducted a naturalistic nonrandomized clinical study to determine the effect of risperidone on psychomotor function compared to haloperidol in schizophrenic patients. In this study the psychomotor performance of 26 patients, who met the ICD-10 and DSM-IV criteria for schizophrenia, was assessed by means of ART-90, a computer-based Act & React Testsystem. 11 patients were on risperidone (mean dosage 4.0 mg) and 15 patients on haloperidol (mean dosage 10.5 mg). Patients were examined at discharge after psychopathological stabilization. In some relevant items the patients in the haloperidol group showed more impaired performance compared to the patients in the risperidone group. These preliminary data indicate a possible beneficial effect of risperidone compared to haloperidol on psychomotor performance and driving ability. Further randomized trials are necessary.

scholarly journals Effects of Haloperidol and Atypical Neuroleptics on Psychomotor Performance and Driving Ability in Schizophrenic Patients

2003 ◽  
Vol 47 (4) ◽  
pp. 212-218 ◽  
Author(s):  
Sabine Kagerer ◽  
Catja Winter ◽  
Hans-Jürgen Möller ◽  
Michael Soyka
Keyword(s):  
Psychomotor Performance ◽  
Driving Ability ◽  
Atypical Neuroleptics ◽  
Schizophrenic Patients
Sign in / Sign up

Export Citation Format

Share Document